Brenna Cholerton1, Adam Omidpanah2, Steven P Verney3, Lonnie A Nelson2, Laura D Baker4, Astrid Suchy-Dicey2, William T Longstreth5,6, Barbara V Howard7, Jeffrey A Henderson8, Thomas J Montine1, Dedra Buchwald2. 1. Department of Pathology, Stanford University, Palo Alto, CA, USA. 2. Department of Community Health, Washington State University, Seattle, WA, USA. 3. Department of Psychology, University of New Mexico, Albuquerque, NM, USA. 4. Department of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. 5. Department of Neurology, School of Medicine University of Washington, Seattle, WA, USA. 6. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. 7. MedStar Health Research Institute, Hyattsville, MD, USA. 8. Black Hills Center for American Indian Health, Rapid City, SD, USA.
Abstract
OBJECTIVES: Insulin resistance is a substantial health issue for American Indians, with type 2 diabetes overrepresented in this population as compared with non-Hispanic whites. Insulin resistance and its related conditions in turn increase risk for dementia and cognitive impairment. The aim of the current study was to determine whether type 2 diabetes and insulin resistance at midlife was associated with later-life cognitive testing in a large sample of older American Indians, aged 65 and older. METHODS: American Indian participants who underwent both fasting blood draw as part of the Strong Heart Study and had subsequent cognitive testing as part of the later adjunct Cerebrovascular Disease and its Consequences in American Indians study were included (n = 790). Regression models examined type 2 diabetes and impaired fasting glucose and subsequent cognitive test performance as part of a longitudinal study design. The relationship between a continuous measure of insulin resistance and later cognitive test performance was assessed using generalized estimating equations. RESULTS: Controlling for demographic and clinical factors, verbal fluency and processing speed/working memory were significantly negatively associated with having type 2 diabetes and with insulin resistance, but not with impaired fasting glucose. CONCLUSION: In this sample of American Indians, type 2 diabetes at midlife was associated with subsequent lower performance on measures of executive function. These results may have important implications for future implementation of diagnostic and intervention services in this population.
OBJECTIVES:Insulin resistance is a substantial health issue for American Indians, with type 2 diabetes overrepresented in this population as compared with non-Hispanic whites. Insulin resistance and its related conditions in turn increase risk for dementia and cognitive impairment. The aim of the current study was to determine whether type 2 diabetes and insulin resistance at midlife was associated with later-life cognitive testing in a large sample of older American Indians, aged 65 and older. METHODS: American Indian participants who underwent both fasting blood draw as part of the Strong Heart Study and had subsequent cognitive testing as part of the later adjunct Cerebrovascular Disease and its Consequences in American Indians study were included (n = 790). Regression models examined type 2 diabetes and impaired fasting glucose and subsequent cognitive test performance as part of a longitudinal study design. The relationship between a continuous measure of insulin resistance and later cognitive test performance was assessed using generalized estimating equations. RESULTS: Controlling for demographic and clinical factors, verbal fluency and processing speed/working memory were significantly negatively associated with having type 2 diabetes and with insulin resistance, but not with impaired fasting glucose. CONCLUSION: In this sample of American Indians, type 2 diabetes at midlife was associated with subsequent lower performance on measures of executive function. These results may have important implications for future implementation of diagnostic and intervention services in this population.
Authors: Katherine J Bangen; Yian Gu; Alden L Gross; Brooke C Schneider; Jeannine C Skinner; Andreana Benitez; Bonnie C Sachs; Regina Shih; Shannon Sisco; Nicole Schupf; Richard Mayeux; Jennifer J Manly; José A Luchsinger Journal: J Am Geriatr Soc Date: 2015-06-11 Impact factor: 5.562
Authors: Elisa T Lee; Thomas K Welty; Linda D Cowan; Wenyu Wang; Dorothy A Rhoades; Richard Devereux; Oscar Go; Richard Fabsitz; Barbara V Howard Journal: Diabetes Care Date: 2002-01 Impact factor: 19.112
Authors: Auriel A Willette; Barbara B Bendlin; Erika J Starks; Alex C Birdsill; Sterling C Johnson; Bradley T Christian; Ozioma C Okonkwo; Asenath La Rue; Bruce P Hermann; Rebecca L Koscik; Erin M Jonaitis; Mark A Sager; Sanjay Asthana Journal: JAMA Neurol Date: 2015-09 Impact factor: 18.302
Authors: Kristine Yaffe; Carrie B Peltz; Susan K Ewing; Charles E McCulloch; Steve R Cummings; Jane A Cauley; Teresa A Hillier; Kristine E Ensrud Journal: J Gerontol A Biol Sci Med Sci Date: 2016-02-03 Impact factor: 6.053
Authors: Geert Jan Biessels; Salka Staekenborg; Eric Brunner; Carol Brayne; Philip Scheltens Journal: Lancet Neurol Date: 2006-01 Impact factor: 44.182
Authors: Andrew Steptoe; Ruth A Hackett; Antonio I Lazzarino; Sophie Bostock; Roberto La Marca; Livia A Carvalho; Mark Hamer Journal: Proc Natl Acad Sci U S A Date: 2014-10-20 Impact factor: 11.205
Authors: Kasim Ortiz; Marc A Garcia; Emily Briceño; Erica D Diminich; Sandra P Arévalo; Irving E Vega; Wassim Tarraf Journal: Res Hum Dev Date: 2020-07-01